Specialist preclinical drug discovery CRO
Ion channels • Cardiac safety • Neuroscience
Good Laboratory Practice (GLP) hERG testing service launched
Neuroscience service now includes CNS drug discovery
Metrion Biosciences
Latest News
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
23rd July 2024
Metrion Biosciences Limited (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.
Metrion Biosciences enhances high-throughput screening services with access to Enamine compound libraries
11th April 2024
Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.
Our Services
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Translational Assays
Integrated Drug Discovery
- High-quality, cost-effective and rapid-turnaround, GLP testing against hERG
- Importance of GLP hERG testing: Ensure data regarding a drug’s potential to cause cardiac arrhythmias is reliable, giving confidence that it can be used in regulatory decision making
- The path to my industrial placement at Metrion Biosciences: Beth Sharp
- Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions
- Industrial placement review: Molly Rowlett
- Development and validation of a dual modality TREK-1 screening assay on the automated patch clamp Qube 384 platform
News and Upcoming Events
Read news including equity financing, launch of GLP hERG Screening service, key appointments, collaboration with KCNC1 Foundation, High-Throughput Screening, expansion of ion channel screening services.
For media enquiries please email us here.
We hold and participate in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities.
Please schedule a meeting with us to discuss any questions or any specific ion channel and assay requirements. We look forward to meeting you shortly.
Our DisPATCHes newsletter
Receive our latest news and insights to your inbox
The DisPATCHes newsletter delivers the latest ion channel, cardiac safety and neuroscience news from Metrion Biosciences.
Subscribe to DisPATCHes to receive the latest science insight, news, upcoming events, webinars, research findings, publications and more.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.